Sasaki Y - Search Results

1

ORL1 and opioid receptor preferences of nociceptin and dynorphin A analogues with Dmp substituted for N-terminal aromatic residues.

Sasaki Y, Kawano S, Kohara H, Watanabe H, Ambo A. Sasaki Y, et al. Bioorg Med Chem. 2006 Apr 1;14(7):2433-7. doi: 10.1016/j.bmc.2005.11.021. Bioorg Med Chem. 2006. PMID: 16321540

2

Dermorphin and deltorphin heptapeptide analogues: replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity.

Ambo A, Murase H, Niizuma H, Ouchi H, Yamamoto Y, Sasaki Y. Ambo A, et al. Among authors: sasaki y. Bioorg Med Chem Lett. 2002 Mar 25;12(6):879-81. doi: 10.1016/s0960-894x(02)00035-5. Bioorg Med Chem Lett. 2002. PMID: 11958984

3

Novel [D-Arg2]dermorphin(1-4) analogs with mu-opioid receptor antagonist activity.

Ambo A, Terashima T, Sasaki Y. Ambo A, et al. Among authors: sasaki y. Chem Pharm Bull (Tokyo). 2002 Oct;50(10):1401-3. doi: 10.1248/cpb.50.1401. Chem Pharm Bull (Tokyo). 2002. PMID: 12372875 Free article.

4

Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity.

Sasaki Y, Sasaki A, Niizuma H, Goto H, Ambo A. Sasaki Y, et al. Among authors: sasaki a. Bioorg Med Chem. 2003 Mar 6;11(5):675-8. doi: 10.1016/s0968-0896(02)00601-6. Bioorg Med Chem. 2003. PMID: 12537996

5

Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.

Ambo A, Niizuma H, Sasaki A, Kohara H, Sasaki Y. Ambo A, et al. Among authors: sasaki a, sasaki y. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1269-72. doi: 10.1016/s0960-894x(03)00110-0. Bioorg Med Chem Lett. 2003. PMID: 12657261

6

Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond.

Okada Y, Fujita Y, Motoyama T, Tsuda Y, Yokoi T, Li T, Sasaki Y, Ambo A, Jinsmaa Y, Bryant SD, Lazarus LH. Okada Y, et al. Among authors: sasaki y. Bioorg Med Chem. 2003 May 1;11(9):1983-94. doi: 10.1016/s0968-0896(03)00068-3. Bioorg Med Chem. 2003. PMID: 12670649

7

Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia.

Okada Y, Tsuda Y, Fujita Y, Yokoi T, Sasaki Y, Ambo A, Konishi R, Nagata M, Salvadori S, Jinsmaa Y, Bryant SD, Lazarus LH. Okada Y, et al. Among authors: sasaki y. J Med Chem. 2003 Jul 17;46(15):3201-9. doi: 10.1021/jm020459z. J Med Chem. 2003. PMID: 12852751

8

Novel 2',6'-dimethyl-L-tyrosine-containing pyrazinone opioid mimetic mu-agonists with potent antinociceptive activity in mice.

Jinsmaa Y, Okada Y, Tsuda Y, Shiotani K, Sasaki Y, Ambo A, Bryant SD, Lazarus LH. Jinsmaa Y, et al. Among authors: sasaki y. J Pharmacol Exp Ther. 2004 Apr;309(1):432-8. doi: 10.1124/jpet.103.060061. Epub 2004 Jan 12. J Pharmacol Exp Ther. 2004. PMID: 14718580

9

2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides.

Sasaki Y, Sasaki A, Ariizumi T, Igari Y, Sato K, Kohara H, Niizuma H, Ambo A. Sasaki Y, et al. Among authors: sasaki a. Biol Pharm Bull. 2004 Feb;27(2):244-7. doi: 10.1248/bpb.27.244. Biol Pharm Bull. 2004. PMID: 14758045 Free article.

10

Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesia.

Jinsmaa Y, Miyazaki A, Fujita Y, Li T, Fujisawa Y, Shiotani K, Tsuda Y, Yokoi T, Ambo A, Sasaki Y, Bryant SD, Lazarus LH, Okada Y. Jinsmaa Y, et al. Among authors: sasaki y. J Med Chem. 2004 May 6;47(10):2599-610. doi: 10.1021/jm0304616. J Med Chem. 2004. PMID: 15115401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,133 results

Search Page

Filters